MARCHETTI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 4.760
AS - Asia 2.091
EU - Europa 1.189
SA - Sud America 423
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 8.503
Nazione #
US - Stati Uniti d'America 4.659
SG - Singapore 865
CN - Cina 645
BR - Brasile 347
UA - Ucraina 242
IT - Italia 216
DE - Germania 201
HK - Hong Kong 194
GB - Regno Unito 154
VN - Vietnam 133
TR - Turchia 113
FI - Finlandia 90
RU - Federazione Russa 63
SE - Svezia 56
CA - Canada 51
MX - Messico 41
PL - Polonia 39
FR - Francia 37
IN - India 34
ID - Indonesia 30
AR - Argentina 28
JP - Giappone 19
ZA - Sudafrica 19
BD - Bangladesh 15
IQ - Iraq 15
LT - Lituania 14
NL - Olanda 14
BE - Belgio 12
ES - Italia 12
CZ - Repubblica Ceca 11
EC - Ecuador 11
AT - Austria 9
CO - Colombia 8
VE - Venezuela 8
PE - Perù 7
CL - Cile 5
IR - Iran 5
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
EG - Egitto 3
IE - Irlanda 3
KE - Kenya 3
KR - Corea 3
RO - Romania 3
UZ - Uzbekistan 3
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
MA - Marocco 2
NG - Nigeria 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
TN - Tunisia 2
UG - Uganda 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.503
Città #
Fairfield 555
Ashburn 530
Singapore 493
Woodbridge 436
Houston 319
Beijing 252
Chandler 251
Jacksonville 241
Seattle 214
Ann Arbor 212
Santa Clara 212
Cambridge 198
Hong Kong 192
Wilmington 180
Nanjing 85
Izmir 76
New York 75
Los Angeles 73
Ferrara 65
Dallas 62
San Diego 58
Munich 57
Princeton 54
Ho Chi Minh City 47
São Paulo 42
Boardman 39
Shanghai 37
Warsaw 36
London 31
Mexico City 31
Hanoi 25
Turku 25
The Dalles 24
Chicago 23
Hefei 23
Nanchang 22
Brooklyn 21
Milan 21
Addison 19
Frankfurt am Main 19
Jakarta 19
Hebei 18
Shenyang 18
Tianjin 18
Tokyo 18
Helsinki 16
Montreal 16
Toronto 16
Chennai 15
Orem 15
Bremen 14
Buffalo 13
Rio de Janeiro 13
Stockholm 13
Brussels 12
San Francisco 12
Atlanta 11
Boston 11
Council Bluffs 11
Denver 11
Johannesburg 10
Moscow 10
Verona 10
Philadelphia 9
Washington 9
Bologna 8
Changsha 8
Falkenstein 8
Leawood 8
Manchester 8
Norwalk 8
Olomouc 8
Poplar 8
San Mateo 8
Ankara 7
Baghdad 7
Da Nang 7
Kunming 7
Ottawa 7
Phoenix 7
Auburn Hills 6
Biên Hòa 6
Brasília 6
Charlotte 6
Ferrara di Monte Baldo 6
Guarulhos 6
Jiaxing 6
Mountain View 6
Mumbai 6
Ribeirão Preto 6
Salt Lake City 6
Zhengzhou 6
Belo Horizonte 5
Falls Church 5
Gavirate 5
Goiânia 5
Jinan 5
Turin 5
Amsterdam 4
Assago 4
Totale 5.937
Nome #
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors 241
Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives. 228
Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor 225
Conjugation of LasR Quorum-Sensing Inhibitors with Ciprofloxacin Decreases the Antibiotic Tolerance of P-aeruginosa Clinical Strains 211
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 210
4-[(4-Methylphenyl)sulfonyl]-1-(triphenylphosphoranylidene)-2-butanone as a convenient precursor for a new formal synthesis of KDO 205
2-Bromoamides as Synthons for Pseudopeptides Containing Aminodicarboxy Units 201
2-Aminoamides and Pseudopeptides Carrying an Amino Group Common to two Residues 201
Design, synthesis and biological evaluation of novel stilbene-based antitumor agents 199
Development of water soluble derivatives of cis-3, 4', 5-trimethoxy-3'- aminostilbene for optimization and use in cancer therapy 194
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 194
Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth 190
4-[(4 '-methylphenyl)sulfonyl]-1-(triphenylphosphoranylidene)-2-butanone as a new four-carbon synthon for substituted divinyl ketones 185
2-Bromoamides. Stereocontrolled Substitution and Application to the Synthesis of Compounds of Biological Interest 180
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities 179
D-(-)-Quinic acid: a chiron store for natural product synthesis 178
4-[(4-Methylphenyl)sulfonyl]-1-(triphenylphosphoranylidene)-2-butanone and its dianion as versatile tools in organic synthesis 177
Diastereoselective synthesis of beta-amino-alpha-hydroxy phosphonates via oxazaborolidine catalyzed reduction of beta-phthalimido-alpha-keto phosphonates 176
Synthesis of 2,5-disubstituted pyrroles and pyrrolidines by intramolecular cyclization of 6-amino-3-keto sulfones 175
Antitumor effects of curcumin and structurally β-diketone modified analogs on multidrug resistant cancer cells 171
Enantioselective reactions of 2-bromopropanamides with primary secondary or tertiary amines. Synthesis of some alaninamides. 160
Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a γδ-T lymphocytes-mediated activation mechanism 154
Synthetic Approach to non-Isosteric Peptidomimetics Related to Human Endothelin 152
Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity 149
Enantioselective approach to tropane skeleton: Synthesis of (1S,5S,6R)-6-Hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-one 145
Base-Promoted Cyclocoupling Reaction of 2-Bromopropanamides and 2-Bromoacetamides with DMF 144
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 143
Polymer-bound 4-benzylsulfonyl-1-triphenylphosphoranylidene-2-butanone as a tool for the solid-phase synthesis of substituted piperidin-4-one derivatives 138
Solid-phase synthesis of indolizidine and quinolizidine derivatives 138
Single Diastereomeric Desaminotyrosylalanyl Tetra- and Heptapeptides with Opioid Antagonistic Activity 137
Un nuovo sintone a quattro atomi di carbonio come equivalente sintetico di divinil chetoni sostituiti 131
Enantioselective formal synthesis of (-)-ovalicin using quinic acid as a chiral template 128
Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells wit a non-specific phase mechanism 127
A Mass Spectroscopy Study on Some 2-Bromopropananilides Derivatives 126
STEREOSELECTIVE SUBSTITUTION IN 2-BROMO AMIDES IN THE PRESENCE OF AG+ OR AG2O 125
null 125
null 125
Versatile Synthesis of New Cytotoxic Agents Structurally Related to Emiasterlins 125
Evidence for exo-anomeric stereoelectronic effect in cyclic orthoester aminals from X-ray structural data. Crystal structures of three 2-amino-1,3-oxazolin-4-one derivatives. 124
Stereoselective synthesis of neutral and cationic 2-heterocyclically substituted propanamides 121
Critical surveys covering the year 1999: total synthesis of natural products 114
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 114
Stereoselective synthesis of N,N-diaryl-2,5-dioxopiperazines from homochiral or racemic 2-bromopropananilides 113
From (-)-quinic acid to 8-azabicyclo[3.2.1]octane framework: Preparation of an enantiopure tropan-6 alpha-ol 112
Dihydroartemisinin-Ursodeoxycholic Bile Acid Hybrids in the Fight against SARS-CoV-2 110
Synthesis and NLRP3-Inflammasome Inhibitory Activity of the Naturally Occurring Velutone F and of Its Non-Natural Regioisomeric Chalconoids 109
Ether-amides and Glycoside-amides from 2-Bromoisobutyramides and Saccharides bearing a Free Primary, Secondary or Anomeric Alcoholic Group. 108
Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells 104
Evidence of the exo-Anomeric Stereoelectronic Effect in Orthoester Aminals from X-Ray Structural Data. Crystal Structures of Three 2-Amino-1,3-oxazolin-4-one derivatives 102
Stereoselective formation of glycoconjugated lactamides from chiral 2-Bromopropanamides. 99
The Fascinating Chemistry of α-Haloamides 98
Structure-Activity Relationship in the Mutagenic Effect of Chiral or Racemic 2-Bromo-2-propanamides on Salmonella typhimurium 97
Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus 97
Reactions of 2-bromopropanamides with conjugated bases of representative beta-dicarbonyl compounds. Synthesis of 2,5-dioxopyrrolidines and oxazolidine-4-ones 94
Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 86
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-a. 81
Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma Cells 80
Sometimes, the Least Demanding Solution Is the Most Suitable: A Careful Survey of NMR Spectra of a Phosphonium Salt Accounted for Its “Unusual Wittig Reaction” 78
Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90. 77
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 53
Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer 27
Totale 8.590
Categoria #
all - tutte 39.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.933
Totale 41.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021464 0 0 0 0 0 67 45 89 33 101 88 41
2021/2022579 29 70 45 21 35 18 24 33 15 36 48 205
2022/2023580 57 45 18 73 93 77 17 67 79 7 31 16
2023/2024367 28 41 26 9 29 89 17 20 10 10 12 76
2024/20251.359 33 27 123 80 158 107 24 59 233 136 207 172
2025/20262.350 464 232 339 575 688 52 0 0 0 0 0 0
Totale 8.590